日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-Line Tislelizumab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Cancer: Three-Year Follow-Up of the Phase 3 RATIONALE-309 Randomized Clinical Trial

一线替雷利珠单抗联合化疗治疗复发或转移性鼻咽癌:RATIONALE-309 III期随机临床试验的三年随访

Yang, Yunpeng; Yen, Chia-Jui; Pan, Jianji; Wang, Hui; Qu, Shenhong; Chen, Nianyong; Chen, Xiaozhong; Sun, Yan; He, Xiaohui; Hu, Chaosu; Lin, Lizhu; Wu, Yanjie; Yuan, Shuai; Chen, Chenqi; Xu, Xingxing; Ma, Xiaopeng; Leaw, Shiangjiin; Zhang, Li; Fang, Wenfeng

Safety and Efficacy of Lucitanib Plus Toripalimab in Advanced Solid Tumors Refractory to Standard Therapies: An Open-Label, Multicenter, Phase II Study

Lucitanib联合Toripalimab治疗对标准疗法耐药的晚期实体瘤的安全性和有效性:一项开放标签、多中心、II期研究

Zhou, Ting; Sun, Haishuang; Chen, Gang; Zhang, Guoping; Wu, Jinsheng; Qu, Shenhong; Han, Yaqian; Hu, Desheng; Ling, Yang; Zheng, Yulong; Liu, Jian; Lin, Lizhu; Li, Yongsheng; Pan, Jianji; Liu, Yanyan; Wang, Cuiying; Fu, Guohong; Feng, Jian; Shi, Jianhua; Cai, Huiming; Li, Meng; Li, Fugen; Wang, Yinbin; Zhang, Li; Yang, Yunpeng

L‑type amino acid transporter 1 in enhancing boron neutron capture therapy: Mechanisms, challenges and future directions (Review)

L型氨基酸转运蛋白1在增强硼中子俘获疗法中的作用:机制、挑战和未来方向(综述)

Zheng, Xiaoqing; Pan, Jianji; Lin, Donghai; Shao, Wei

Watch-and-wait strategy in patients with objective response after immuno-chemotherapy for locally recurrent nasopharyngeal carcinoma: a pilot study

对接受免疫化疗后局部复发性鼻咽癌患者采取观察等待策略:一项初步研究

Zhang, Quxia; Huang, Wanfang; Chen, Xinlan; Yan, Zhiwei; Huang, Daqiang; Xu, Hanchuan; Zheng, Yahan; Zhu, Lili; Pan, Caizhu; Pan, Jianji; Lin, Shaojun; Huang, Chaobin; Guo, Qiaojuan

Boron Neutron Capture Therapy as a Novel Approach for Chondrosarcoma: Case Study of Tumor Reduction and Long-term Control

硼中子俘获疗法作为软骨肉瘤的一种新方法:肿瘤缩小和长期控制的病例研究

Hong, Junqiang; Liu, Yuan-Hao; Zhu, Xiaohua; Teng, Yi-Chiao; Lin, Xiaoyi; Shu, Diyun; Lai, Youqun; Cao, Ye; Gong, Qiuping; Fu, Shuang; Xu, Wenyu; Lai, Qiuli; Liu, Xingyan; Zhou, Ping; Mei, Mu; Ying, Mingang; Huang, Cheng; Pan, Jianji

Burden of laryngeal cancer attributable to occupational asbestos exposure in China: A comprehensive analysis from 1990 to 2021

中国职业性石棉暴露导致的喉癌负担:1990年至2021年的综合分析

Chen, Bijuan; Zhan, Zhouwei; Yu, Sisi; Huang, Jiali; Chen, Chuying; Wang, Jie; Pan, Jianji; Lin, Shaojun; Xu, Yun

Risk-adapted locoregional radiotherapy strategies based on a prognostic nomogram for de novo metastatic nasopharyngeal carcinoma patients treated with chemoimmunotherapy

基于预后列线图的风险适应性局部区域放射治疗策略,用于接受化疗免疫治疗的新发转移性鼻咽癌患者

Chen, Yuebing; Chen, Chuying; Peng, Hewei; Lin, Shaojun; Pan, Jianji; Zheng, Huiping; Zong, Jingfeng; Lin, Cheng

Plasma Epstein-Barr virus microRNA BART8-3p as a potential biomarker for detection and prognostic prediction in early nasopharyngeal carcinoma

血浆中 Epstein-Barr 病毒 microRNA BART8-3p 作为早期鼻咽癌检测和预后预测的潜在生物标志物

Lin, Cheng; Chen, Yuebing; Lin, Xiandong; Peng, Hewei; Huang, Juan; Lin, Shaojun; Pan, Jianji; Li, Meifang; Zong, Jingfeng

Long-term trends and future projections of larynx cancer burden in China: a comprehensive analysis from 1990 to 2030 using GBD data

中国喉癌负担的长期趋势和未来预测:基于GBD数据的1990年至2030年综合分析

Chen, Bijuan; Zhan, Zhouwei; Fang, Weining; Zheng, Yahan; Yu, Sisi; Huang, Jiali; Pan, Jianji; Lin, Shaojun; Guo, Qiaojuan; Xu, Yun

Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial

托瑞普利单抗联合化疗治疗复发性或转移性鼻咽癌:JUPITER-02随机临床试验

Mai, Hai-Qiang; Chen, Qiu-Yan; Chen, Dongping; Hu, Chaosu; Yang, Kunyu; Wen, Jiyu; Li, Jingao; Shi, Yingrui; Jin, Feng; Xu, Ruilian; Pan, Jianji; Qu, Shenhong; Li, Ping; Hu, Chunhong; Liu, Yi-Chun; Jiang, Yi; He, Xia; Wang, Hung-Ming; Lim, Wan-Teck; Liao, Wangjun; He, Xiaohui; Chen, Xiaozhong; Wang, Siyang; Yuan, Xianglin; Li, Qi; Lin, Xiaoyan; Jing, Shanghua; Chen, Yanju; Lu, Yin; Hsieh, Ching-Yun; Yang, Muh-Hwa; Yen, Chia-Jui; Samol, Jens; Luo, Xianming; Wang, Xiaojun; Tang, Xiongwen; Feng, Hui; Yao, Sheng; Keegan, Patricia; Xu, Rui-Hua